Rocket Lab SEC Filings

This 424B3 prospectus supplement updates the October 2021 prospectus with the April 15, 2022 Form 8-K. The 8-K announces the 2022 Annual Meeting date and revised deadlines for stockholder proposals due to the meeting date advancing more than 30 days. It is relevant to investors for governance and proxy participation purposes.

This is a prospectus supplement incorporating an 8-K filed April 15, 2022. It announces the 2022 Annual Meeting date of June 23, 2022 and sets a new shareholder proposal deadline of April 25, 2022 due to the meeting advancing more than 30 days. The update is procedural and informs investors of governance timelines.

Rocket Lab's Board set the 2022 Annual Meeting for June 23, 2022. Due to the date advancing more than 30 days from prior notice, new deadlines apply for stockholder proposals under Rule 14a-8 and Bylaws. Proposals must be received by April 25, 2022. No financial impact.

This 424B3 prospectus supplement updates prior disclosures with a Form 8-K/A filed March 29, 2022. It reports that the January 18, 2022 SolAero acquisition no longer requires audited financials or pro forma information under Regulation S-X after reevaluation using 2021 year-end results. Investors receive confirmation that disclosure obligations are reduced.

This 424B3 prospectus supplement updates the October 2021 prospectus with a March 29, 2022 Form 8-K/A. The amendment states that after reevaluating significance using 2021 financials, no audited financial statements or pro forma information are required for the January 18, 2022 SolAero acquisition. Investors receive clarification that the acquisition does not trigger additional Regulation S-X disclosures.

This 8-K/A amends the January 19, 2022 8-K regarding Rocket Lab's acquisition of SolAero Holdings, Inc., completed on January 18, 2022. After reevaluating significance using 2021 financials from the March 24, 2022 10-K, the company determined no audited financial statements or pro forma information for SolAero are required under Regulation S-X. Investors benefit from clarity that the deal lacks material financial impact requiring extra disclosures.

This filing is a prospectus supplement attaching Rocket Lab's 2021 10-K. Key facts include revenue of $62.2M (up 77% YoY), net loss of $117.3M, 20 successful Electron launches, and development of Neutron vehicle. Relevance to investors is an update on business operations, risks, and financial position post-SPAC merger.

This 424B3 filing supplements the October 7, 2021 prospectus with the March 24, 2022 10-K for fiscal year ended December 31, 2021. Key facts include 20 successful Electron launches deploying 109 spacecraft, development of Neutron vehicle, space systems expansion via acquisitions, and emerging growth company status. It provides investors updated business, financial, and risk information for RKLB common stock trading at $9.00.

Rocket Lab issued a press release on March 24, 2022, announcing the launch window for its next Electron mission and providing an update to its first quarter 2022 revenue guidance. The information is furnished under Item 7.01 Regulation FD and not deemed filed. No specific financial figures or new launch dates were detailed in the filing.

Rocket Lab reported FY2021 revenue of $62.2M, up 77% YoY from $35.2M, driven by higher launch pricing and space systems growth. Gross margin improved to -3% from -34%, but operating loss widened to $102M due to R&D and SG&A expansion post-SPAC. Backlog reached $242M with strong cash position of $691M after Business Combination.